| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.34 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |